United States

Health News


Amgen gets fast FDA review for adding heart benefits to cholesterol drug label 6:24pm EDT

Amgen Inc said on Thursday the U.S. Food and Drug Administration granted priority review to the company's request to add important heart safety data to the label of its expensive injectable cholesterol drug Repatha.

More Headlines

Trans teens worse off on health measures than peers

(Reuters Health) - Teenagers who identify as transgender or gender nonconforming may be worse off on several health measures than their non-transgender classmates, suggests a new study from Minnesota.

5:30pm EDT

Vaccine lessens severity of whooping cough infections

(Reuters Health) - Even though vaccinations don’t always prevent whooping cough, people have milder symptoms of the respiratory illness and lower odds of serious complications with the vaccine than without it, a U.S. study suggests.

4:54pm EDT

Adult colorectal cancer risk tied to weight as a teen

(Reuters Health) - Being overweight or obese as a teenager may increase a person’s risk of developing colorectal cancer as an adult, suggests a large Israeli study.

5:25pm EDT

Slug slime inspires new kind of surgical glue

LONDON Scientists have developed an experimental surgical glue inspired by the mucus secreted by slugs that could offer an alternative to sutures and staples for closing wounds. | Video

Science, 2:35pm EDT

Health Watch Graphics